In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks.Click here for all the photos of this event.
Best PhD Thesis 2017: Pascal MiesenTitle of his thesis: Untangling the piRNA pathway in the arbovirus vector mosquito Aedes aegypti.
Best Master Thesis 2017: Anouk BeckerTitle of her thesis: Novel strategy for targeted nanovaccines for cancer immunotherapy
Breakthrough paper 2017: Tania Crişan, et al.Title: Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.
Proceedings of the National Academy of Science USA. 114: 5485-5490, 2017.
- Edyta Swider: € 500,- to visit the ISMRM conference in Paris, France
- Jos Smits: € 1000,- to visit the International Investigative Dermatology meeting in Orlando, Florida, USA
- Vera Dunlock: € 700,- to visit the conference “Tetraspanin scaffolds in cancer and infectious disease” in Arizona, USA
- Nicole Visser: € 1000,- for a work placement at the Johns Hopkins Hospital in Baltimore, USA
- Daphne Lobeek: € 400,- to visit the 8'n international Symposium Sentinel Node Biopsy in Head and Neck Cancer - Consensus Meeting in London, UK
- Hanna Niehues: € 1000,- to visit the International Investigative Dermatology meeting in Orlando, Florida, USA
- Martijn van den Bosch: € 500,- to visit the OARSI 2018 World Congress in Liverpool, UK
Related news items
Terrestrial bacteria can grow on nutrients from space26 May 2020
Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.read more
Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images22 May 2020
In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.read more
First clinical trial with genetically modified malaria vaccine completed22 May 2020
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.read more
New step in the development of a vaccine against malaria22 May 2020
A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.read more